David Booth,Jacob George,Mohanned Eslam,Golo Ahlenstiel,Kate OConnor
申请号：
US15325704
公开号：
US20180263556A1
申请日:
2015.07.17
申请国别(地区):
US
年份:
2018
代理人:
摘要：
This invention relates to molecular diagnostics and, more specifically DNA-based tests for the prognosis and/or monitoring of fibrotic disease progression in humans, and processes for stratifying patients based on their likely rates of fibrotic disease progression. The invention also relates to the field of therapy for fibrotic disease, based on such prognoses, monitoring and stratification results, such as in monitoring and/or stratifying and/or treating patients having a higher likelihood of rapid fibrotic disease progression.
